These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21067897)

  • 21. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation: results of a randomised double blind placebo controlled study.
    O'Rourke B; Barbir M; Mitchell AG; Yacoub MH; Banner NR
    Int J Cardiol; 2004 Apr; 94(2-3):235-40. PubMed ID: 15093987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
    Reyderman L; Kosoglou T; Cutler DL; Maxwell S; Statkevich P
    Curr Med Res Opin; 2005 Aug; 21(8):1171-9. PubMed ID: 16083526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.
    Bruckert E; Lièvre M; Giral P; Crepaldi G; Masana L; Vrolix M; Leitersdorf E; Dejager S
    Am J Geriatr Cardiol; 2003; 12(4):225-31. PubMed ID: 12888702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvastatin with and without niacin for hypercholesterolemia.
    Jacobson TA; Chin MM; Fromell GJ; Jokubaitis LA; Amorosa LF
    Am J Cardiol; 1994 Jul; 74(2):149-54. PubMed ID: 8023779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.
    Holdaas H; Wanner C; Abletshauser C; Gimpelewicz C; Isaacsohn J
    Int J Cardiol; 2007 Apr; 117(1):64-74. PubMed ID: 16889855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New trends in lipidology. Which patient benefits from cholesterol lowering therapy?].
    Internist (Berl); 1998 Apr; 39(4 Suppl Welcher Pa):1-4. PubMed ID: 9589329
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.
    Banga JD; Jacotot B; Pfister P; Mehra M
    Am J Med; 1994 Jun; 96(6A):87S-93S. PubMed ID: 8017473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M; Valacio R; Reckless JP; Ghosh AK; Findlay IN; Ghosh MK; Passmore AP; Fulcher RA
    Coron Artery Dis; 1998; 9(9):583-90. PubMed ID: 9861520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients.
    Melchor JL; Gracida C
    Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypotensive effect of an inhibitor of cholesterol synthesis (fluvastatin). A pilot study].
    Abetel G; Poget PN; Bonnabry JP
    Schweiz Med Wochenschr; 1998 Feb; 128(7):272-7. PubMed ID: 9540154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvastatin: efficacy and safety in reducing cardiac events.
    Chan MY; Lee CH
    Expert Opin Pharmacother; 2005 Sep; 6(11):1883-95. PubMed ID: 16144508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice.
    Schwed A; Fallab CL; Burnier M; Waeber B; Kappenberger L; Burnand B; Darioli R
    J Clin Pharmacol; 1999 Apr; 39(4):402-9. PubMed ID: 10197299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin.
    Gottsäter A; Anwaar I; Lind P; Mattiasson I; Lindgärde F
    Blood Coagul Fibrinolysis; 1999 Apr; 10(3):133-40. PubMed ID: 10357007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia.
    Peters TK; Muratti EN; Mehra M
    Drugs; 1994; 47 Suppl 2():64-72. PubMed ID: 7517836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
    Davidson MH
    Am J Med; 1994 Jun; 96(6A):41S-44S. PubMed ID: 8017466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and lipid-lowering effect of fluvastatin in hypercholesterolaemic patients on maintenance haemodialysis.
    Ichimaru N; Takahara S; Moriyama T; Kondo M; Nonomura N; Tanaka T; Wang JD; Imai E; Okuyama A; Kondo Y
    J Int Med Res; 2004; 32(1):45-52. PubMed ID: 14997705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy with fluvastatin and niacin in hypercholesterolemia: a preliminary report on safety.
    Jacobson TA; Amorosa LF
    Am J Cardiol; 1994 May; 73(14):25D-29D. PubMed ID: 8198020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
    Hagen E; Istad H; Ose L; Bodd E; Eriksen HM; Selvig V; Bard JM; Fruchart JC; Borge M; Wolf MC
    Eur J Clin Pharmacol; 1994; 46(5):445-9. PubMed ID: 7957541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.
    Holdaas H; Fellström B; Jardine AG; Holme I; Nyberg G; Fauchald P; Grönhagen-Riska C; Madsen S; Neumayer HH; Cole E; Maes B; Ambühl P; Olsson AG; Hartmann A; Solbu DO; Pedersen TR;
    Lancet; 2003 Jun; 361(9374):2024-31. PubMed ID: 12814712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.